Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05010005
Title A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

prolymphocytic leukemia

T-cell large granular lymphocyte leukemia

peripheral T-cell lymphoma

cutaneous T cell lymphoma

nasal type extranodal NK/T-cell lymphoma

anaplastic large cell lymphoma

aggressive NK-cell leukemia

adult T-cell leukemia

angioimmunoblastic T-cell lymphoma

follicular lymphoma

Therapies

Duvelisib + Ruxolitinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.